NCT05832307 The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
| NCT ID | NCT05832307 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Influenza |
| Study Type | INTERVENTIONAL |
| Enrollment | 22,000 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22,000 participants in total. It began in 2024-10-31 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
Eligibility Criteria
Inclusion Criteria: * At least 6 months of age * Admitted to an inpatient unit at a participating health system Exclusion: \- Admission to critical care sites or hematology-oncology services Exclusion Criteria: * At least 6 months of age * Admitted to an inpatient unit at a participating health system Exclusion: \- Admission to critical care sites or hematology-oncology services
Contact & Investigator
Suchitra Rao
PRINCIPAL INVESTIGATOR
University of Colorado, Children's Hospital Colorado
Frequently Asked Questions
Who can join the NCT05832307 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, up to 99 Years, studying Influenza. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05832307 currently recruiting?
Yes, NCT05832307 is actively recruiting participants. Contact the research team at suchitra.rao@childrenscolorado.org for enrollment information.
Where is the NCT05832307 trial being conducted?
This trial is being conducted at Chicago, United States, Seattle, United States.
Who is sponsoring the NCT05832307 clinical trial?
NCT05832307 is sponsored by University of Colorado, Denver. The principal investigator is Suchitra Rao at University of Colorado, Children's Hospital Colorado. The trial plans to enroll 22,000 participants.